SCHEMBL5716528

SCHEMBL5716528

CC(C)(C)OC(=O)Nc1cnn(Cc2cccnc2)c1N

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.44
ALDH1A1 P00352 2/20 0.44
PKM P14618 1/20 0.44
NAMPT P43490 2/20 0.44
HDAC3 O15379 2/20 0.41
HDAC1 Q13547 2/20 0.41
HDAC2 Q92769 2/20 0.41
RAB9A P51151 1/20 0.41
SLC16A3 O15427 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
IDO1 P14902 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
HDAC9 Q9UKV0 1/20 0.39
HDAC5 Q9UQL6 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13989338 0.84 ALDH1A1 (0.40) ALDH1A1HDAC3HDAC1CYP1A2CYP2C9
SCHEMBL26414586 0.73 CYP3A4 (0.58) CYP3A4NAMPTRAB9ACYP1A2CYP2C9
SCHEMBL9669683 0.72 ALOX5 (0.54) CYP3A4ALDH1A1PKMNAMPTRAB9A
SCHEMBL9439389 0.71 CYP3A4 (0.59) CYP3A4ALDH1A1PKMNAMPTRAB9A
SCHEMBL5716532 0.71 ALDH1A1 (0.46) CYP3A4ALDH1A1PKMSLC16A3CYP1A2
SCHEMBL479925 0.71 CYP3A4 (0.72) CYP3A4ALDH1A1PKMNAMPTCYP1A2
SCHEMBL10235975 0.70 NAMPT (0.47) CYP3A4PKMNAMPTRAB9A
SCHEMBL2413941 0.70 NAMPT (0.51) CYP3A4NAMPTHDAC3HDAC1HDAC2
SCHEMBL13989341 0.70 ALDH1A1 (0.64) ALDH1A1PKMCYP1A2
SCHEMBL30546609 0.70 NAMPT (0.46) CYP3A4NAMPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7462204-B2 Cationic diaminopyrazoles, a process for producing them and colorants containing these compounds WELLA AG (DE) 2008-12-09 US disclosed
US-7462204-B2 Cationic diaminopyrazoles, a process for producing them and colorants containing these compounds WELLA AG (DE) 2008-12-09 US disclosed
US-20070056120-A1 Cationic diaminopyrazoles, a process for producing them and colorants containing these compounds HFC PRESTIGE INTERNATIONAL OPERATIONS SWITZERLAND SÀRL (CH) 2007-03-15 US disclosed
US-20070056120-A1 Cationic diaminopyrazoles, a process for producing them and colorants containing these compounds HFC PRESTIGE INTERNATIONAL OPERATIONS SWITZERLAND SÀRL (CH) 2007-03-15 US disclosed
EP-1687280-A1 CATIONIC DIAMINOPYRAZOLES, A METHOD FOR THE PRODUCTION THEREOF AND DYES CONTAINING THESE COMPOUNDS Wella Aktiengesellschaft (DE) 2006-08-09 EP disclosed
WO-2005051918-A1 CATIONIC DIAMINOPYRAZOLES, A METHOD FOR THE PRODUCTION THEREOF AND DYES CONTAINING THESE COMPOUNDS WELLA AKTIENGESELLSCHAFT (DE) 2005-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070056120-A1 Cationic diaminopyrazoles, a process for producing them and colorants containing these compounds KRT18, DSP, TUBA4A CYP3A4 1583/4885ALDH1A1 978/4885PKM 463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.